Renowned analyst Altcoin Sherpa believes that gaming altcoin BEAM will outperform its competitors in the cryptocurrency subsector. BEAM has already ...
Protagenic Therapeutics achieves milestone in Phase I trial for PT00114, a compound for treating stress-related neuro-psychiatric disorders. No adverse reactions ...